OTC derivatives, holistic data and standard reporting: a video interview with Finextra

Contributor: Tony Scianna

During a recent trip to snowy London, I was fortunate to finally meet Finextra’s Liz Lumley in person. As the multimedia and special projects editor, Liz conducted a brief video interview with me that is now live on the Finextra site.

In the video, you will see us discus several topics that I believe are only going to become a bigger conversation as we move into 2011. This includes the move toward central counterparty clearing of OTC derivatives; the imperative for centralized, holistic, real-time data aggregation; and on-demand, standardized reporting. I may sound like a broken record, but when it comes to the new financial regulatory landscape, we are still just beginning to learn what the regulators have in mind for the industry in the coming months and years.

Click the video below to watch (it will take you to Finextra’s website) and then join the conversation that Liz and I have started. Here on this blog, I’d encourage you to comment on a few relevant questions: What are your thoughts regarding the move to central clearing of OTC derivatives? Do you agree with Liz that the notion of a centralized, holistic, real-time view of your data and risk is “mythical?” This time next year, how will this conversation sound different?

SHARE